Iodine Deficiency Medication
- Author: Stephanie L Lee, MD, PhD; Chief Editor: George T Griffing, MD more...
Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications. Medications used in iodine deficiency include antithyroid agents (potassium iodide) and thyroid products (levothyroxine).
Antithyroid Agents
Class Summary
Iodine deficiency has been treated at a population level by several methods, including voluntary use of iodized salt, iodine supplementation in bread and water, and oral/intramuscular administration of iodized oil. The simplest and least expensive treatment is to have the patient purchase and use iodized salt.
Potassium iodide (SSKI)
Potassium iodide is an option in industrialized counties. Absorption from the gastrointestinal tract is rapid and complete. The skin and lungs also can absorb iodine. Iodine equilibrates in extracellular fluids and is specifically concentrated by the thyroid gland.
Thyroid Products
Class Summary
Thyroid hormone, L-thyroxine, may be used to treat iodine deficiency, because the chemical content of iodine is approximately 60% by weight.
Levothyroxine (Synthroid, Levothroid, Levoxyl)
Levothyroxine (L-T4) is generally effective in treating iodine deficiency. It is a considerably more expensive preparation than other forms of iodine (eg, iodized salt), especially when its cost is combined with the added expense of measuring TSH levels to assure that the supplemental L-T4 has not resulted in iatrogenic hyperthyroidism.
Alternatively, thyroid hormone therapy has been used with caution to shrink the goiter of iodine deficiency. An L-T4 dose is chosen that maintains the TSH in the lower part of the reference range. TSH levels should be monitored carefully to avoid thyrotoxicosis due to autonomous nodules in the iodine deficiency goiter.
Zimmermann MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. Lancet. Oct 4 2008;372(9645):1251-62. [Medline].
de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. Sep 2008;29(3):195-202. [Medline].
Zimmermann MB. Iodine deficiency in pregnancy and the effects of maternal iodine supplementation on the offspring: a review. Am J Clin Nutr. Feb 2009;89(2):668S-72S. [Medline].
WHO Secretariat, Andersson M, de Benoist B, Delange F, Zupan J. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr. Dec 2007;10(12A):1606-11. [Medline].
Delange F. Optimal iodine nutrition during pregnancy, lactation and neonatal period. Int J Endocrinol Metab. 2004;89:3851.
Azizi F, Smyth P. Breastfeeding and maternal and infant iodine nutrition. Clin Endocrinol (Oxf). May 2009;70(5):803-9. [Medline].
Pearce EN, Pino S, He X, Bazrafshan HR, Lee SL, Braverman LE. Sources of dietary iodine: bread, cows' milk, and infant formula in the Boston area. J Clin Endocrinol Metab. Jul 2004;89(7):3421-4. [Medline].
Hollowell JG, Staehling NW, Hannon WH, et al. Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutrition Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab. Oct 1998;83(10):3401-8. [Medline]. [Full Text].
Caldwell KL, Jones R, Hollowell JG. Urinary iodine concentration: United States National Health And Nutrition Examination Survey 2001-2002. Thyroid. Jul 2005;15(7):692-9. [Medline].
Caldwell KL, Miller GA, Wang RY, Jain RB, Jones RL. Iodine status of the U.S. population, National Health and Nutrition Examination Survey 2003-2004. Thyroid. Nov 2008;18(11):1207-14. [Medline].
Caldwell KL, Makhmudov A, Ely E, Jones RL, Wang RY. Iodine Status of the U.S. Population, National Health and Nutrition Examination Survey, 2005-2006 and 2007-2008. Thyroid. Feb 16 2011;[Medline].
Zimmermann MB, Aeberli I, Torresani T, et al. Increasing the iodine concentration in the Swiss iodized salt program markedly improved iodine status in pregnant women and children: a 5-y prospective national study. Am J Clin Nutr. Aug 2005;82(2):388-92. [Medline]. [Full Text].
Williams GR. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. Jun 2008;20(6):784-94. [Medline].
Zimmermann MB, Wegmuller R, Zeder C, et al. Rapid relapse of thyroid dysfunction and goiter in school-age children after discontinuation of salt iodization. Am J Clin Nutr. Apr 2004;79(4):642-5. [Medline]. [Full Text].
Santiago-Fernandez P, Torres-Barahona R, Muela-Martínez JA, et al. Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab. Aug 2004;89(8):3851-7. [Medline]. [Full Text].
Zimmermann MB, Moretti D, Chaouki N, et al. Development of a dried whole-blood spot thyroglobulin assay and its evaluation as an indicator of thyroid status in goitrous children receiving iodized salt. Am J Clin Nutr. Jun 2003;77(6):1453-8. [Medline]. [Full Text].
Zimmermann MB. Iodine requirements and the risks and benefits of correcting iodine deficiency in populations. J Trace Elem Med Biol. 2008;22(2):81-92. [Medline].
Cerqueira C, Knudsen N, Ovesen L, et al. Association of iodine fortification with incident use of anti-thyroid medication - A Danish nationwide study. J Clin Endocrinol Metab. Apr 14 2009;[Medline].
| Iodine Deficiency | None | Mild | Moderate | Severe |
| Median urine iodine, mcg/L | >100 | 50-99 | 20-49 | < 20 |
| Goiter prevalence | < 5% | 5-20% | 20-30% | >30% |
| Neonatal thyroid stimulating hormone (TSH), >5 IU/mL whole blood | < 3% | 3-20% | 20-40% | >40% |
| Cretinism | 0 | 0 | + | + |
| Adapted from the World Health Organization (WHO)/United Nations Children's Fund (UNICEF)/International Council for Control of Iodine Deficiency Disorders (ICCIDD). | ||||

